Found: 8
Select item for more details and to access through your institution.
National CIL Administrative Review: Status and Disposition.
- Published in:
- Journal of Rehabilitation Administration, 2005, v. 29, n. 4, p. 269
- By:
- Publication type:
- Article
Assessing cost effectiveness of empirical and prophylactic therapy for managing leptospirosis outbreaks.
- Published in:
- Epidemiology & Infection, 2009, v. 137, n. 9, p. 1323, doi. 10.1017/S0950268808001751
- By:
- Publication type:
- Article
Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 806, doi. 10.1111/bjh.17072
- By:
- Publication type:
- Article
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors.
- Published in:
- Bone Marrow Transplantation, 2014, v. 49, n. 2, p. 185, doi. 10.1038/bmt.2013.168
- By:
- Publication type:
- Article
Brentuximab Vedotin‐Nivolumab alone and then with Rituximab‐Cyclophosphamide‐Doxorubicin‐Prednisone as Frontline Therapy of Primary Mediastinal Large B‐cell Lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 167, doi. 10.1002/hon.3163_T03
- By:
- Publication type:
- Article
Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 430, doi. 10.1002/hon.3164_317
- By:
- Publication type:
- Article
IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO POLA‐R‐CHP TREATMENT REDUCES TUMOR MICROENVIRONMENT DEPENDENCY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 223, doi. 10.1002/hon.3163_146
- By:
- Publication type:
- Article
CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 175, doi. 10.1002/hon.3163_111
- By:
- Publication type:
- Article